Viridian Therapeutics, Inc. (VRDN)

NASDAQ: VRDN · Real-Time Price · USD

20.84

+1.53 (7.92%)

At close: Aug 4, 2026, 4:00 PM EDT

20.44

-0.40 (-1.92%)

After-hours: Aug 4, 2026, 7:34 PM EDT

Viridian Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	176.35	212.38	99.59	102.83	155.58	42.3
Short-Term Investments	585.84	662.27	617.99	374.54	268.97	154.67
Cash & Short-Term Investments	762.18	874.65	717.58	477.37	424.55	196.97
Cash Growth	19.72%	21.89%	50.32%	12.44%	115.55%	54.31%
Accounts Receivable	-	-	-	0.1	0.1	0.45
Other Current Assets	22.56	19.58	20.88	9.01	6.52	2.75
Total Current Assets	784.74	894.23	738.46	486.48	431.17	200.16
Net Property, Plant & Equipment	3.39	3.65	3.44	3.34	2.94	2.06
Other Long-Term Assets	0.89	1.54	0.5	0.6	0.98	1.49
Total Assets	789.02	899.42	742.4	490.42	435.09	203.71

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	13.31	8.68	2.14	2.24	14.23	2.33
Accrued Expenses	38.49	62.01	45.73	24.11	18.83	11.02
Unearned Revenue	-	-	-	0.29	0.29	0.29
Total Current Liabilities	51.81	70.7	47.87	26.64	33.35	13.64
Long-Term Debt	50.44	49.94	20.58	20.21	4.65	-
Other Long-Term Liabilities	50.77	56.62	2.31	1.56	2.03	2.36
Total Long-Term Liabilities	101.2	106.56	22.89	21.77	6.68	2.36
Total Liabilities	153.01	177.25	70.76	48.4	40.03	15.99

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Preferred Stock	132.06	132.06	188.89	206.52	142.15	133.83
Common Stock	1.03	1.02	0.81	0.54	0.41	0.24
Additional Paid-in Capital	1,947	1,927	1,478	960.54	741.07	412.1
Accumulated Other Comprehensive Income	-0.56	0.45	-0.01	0.34	-0.39	-0.16
Retained Earnings	-1,443	-1,338	-995.86	-725.91	-488.17	-358.3
Shareholders' Equity	636.01	722.17	671.64	442.02	395.06	187.72
Total Liabilities & Equity	789.02	899.42	742.4	490.42	435.09	203.71

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	50.44	49.94	20.58	20.21	4.65	0
Net Cash (Debt)	711.75	824.71	697	457.17	419.91	196.97
Net Cash Growth	15.55%	18.32%	52.46%	8.87%	113.19%	54.31%
Net Cash Per Share	7.91	9.72	10.27	10.21	13.09	16.53
Book Value	636.01	722.17	671.64	442.02	395.06	187.72
Book Value Per Share	7.07	8.52	9.89	9.88	12.31	15.75
Tangible Book Value	636.01	722.17	671.64	442.02	395.06	187.72
Tangible Book Value Per Share	7.07	8.52	9.89	9.88	12.31	15.75

SEC Filings: 10-K · 10-Q